Renalytix AI plc

Company Profile

Company website
Medical Equipment and Services (Medical Equipment)

Renalytix AI plc (AIM: RENX) is a leading developer of artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney disease, one of the most common and costly chronic medical conditions globally, to provide improved patient outcomes and advance value-based care. 

Investor Access

01 Feb
Event information
Click here to watch Renalytix AI plc’s latest investor presentation on the digital platform Investor Meet Company.
Financial Calendar
 Event  Date
Year End 30 June
Half  Year End 31 December
Preliminary Results* October
Interim Results* March
AGM* December

* Months based on previous announcements of this kind